CROSSROADS STRATEGIES, LLC
CROSSROADS STRATEGIES, LLC filed a Q3 report for HALEON US HOLDINGS LLC on October 19, 2025, reporting $50,000 in lobbying income.
Lobbying for HALEON US HOLDINGS LLC · consumer health care company
Issues related to healthcare and payment for over-the-counter drugs; General education of over-the-counter switches, including reauthorization of the Over-the-Counter Monograph Drug User Fee Act and policies impacting a Nonprescription Drug Product with an Additional Condition for Nonprescription Use; H.R.4273/S.2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R.5371, Continuing Appropriations and Extensions Act, 2026.
Issues related to coverage of over-the-counter products with FSAs and HSAs.
Policies impacting access to over-the-counter products; FY2026 Financial Services and General Government Appropriations Act process (H.R.5166).
Policies impacting the supply chain and manufacturing of over-the-counter pharmaceutical products including tariffs.